Menu
Quest Peptides has developed three orally administered peptide products, in capsule form, that maintain adequate and often preferred effects. This method of administration is often preferred by patients because it is fast, easy, and minimizes discomfort.
Oral peptides, like those from Quest Medical, offer a significant breakthrough in how peptides are administered, focusing on ease and efficiency. Unlike traditional injections, oral peptides such as BPC-157 Arginate, Dihexa, and KPV are designed for easy consumption and improved patient comfort. Their innovative formulation ensures that a sufficient amount reaches the target area in the body, overcoming common obstacles like degradation in the stomach. This method not only enhances patient compliance but also makes therapy more accessible, heralding a new era in treatment possibilities.
While many peptides necessitate parenteral administration, some are suitable for oral consumption. The primary consideration with oral administration revolves around the product’s bioavailability, which pertains to the quantity of the product that reaches the desired site to elicit an effect. The concern stems from the possibility that an insufficient amount of the intended product may be accessible after it traverses the stomach and undergoes first-pass metabolism.
Strive Peptides has developed three orally administered peptide products, in capsule form, that maintain adequate and often preferred effects. This method of administration is often preferred by patients because it is fast, easy, and minimizes discomfort.
Oral Peptides offered by Quest Medical Include:
Derived from a natural body protection compound, BPC- 157 is recognized for its wound healing properties in the GI tract and various body tissues. Resistant to harsh GI conditions, it is effective against issues like inflammatory bowel disease and ulcers when taken orally.
Thymosin Beta-4 (TB-4) is a naturally occurring peptide that plays a crucial role in promoting tissue repair and regeneration. It is known for its ability to support healing processes in various tissues, including muscle, skin, and cardiovascular structures. TB-4 is recognized for its potential therapeutic applications in enhancing recovery from injuries and promoting overall tissue health.
Dihexa, derived from Nle1-angiotensin IV, enhances memory and synaptic connections in Alzheimer’s models. This orally active compound crosses the blood-brain barrier, boasting a long half-life and potent anti-dementia effects. It may prevent and improve Alzheimer’s symptoms by reducing amyloid beta production.
Bringing Clarity Out Of Confusion
Oral peptides are short chains of amino acids that can be administered orally. Unlike traditional peptides that require injections, oral peptides are designed to be absorbed through the digestive system while maintaining their efficacy.
Bioavailability refers to the proportion of a substance that enters the circulation when introduced into the body and so is able to have an active effect. For oral peptides, high bioavailability ensures that a significant amount of the peptide reaches the desired site of action.
BPC-157 Arginate has an enhanced formulation that provides longer shelf life and maintains 90% bioavailability even after 5 hours in gastric acid, significantly higher than the acetate version.
Yes, Dihexa has shown promise in facilitating the formation of new functional synaptic connections and augmenting memory consolidation, which could prevent and improve symptoms of Alzheimer’s Disease.
Despite its small size, KPV retains some of the desirable properties of alpha-melanocyte-stimulating hormone and is easily absorbed orally, making it effective for treating various inflammatory conditions.
As with any supplement or medication, side effects can vary depending on the individual and the specific peptide. It’s important to consult with a healthcare provider before starting any new treatment.
You can inquire about purchasing our oral peptide products by contacting us directly through the information provided in the “Contact Us” section of our website.
